Jeff Carlson writes about mobile technology for CNET. He is also the author of dozens of how-to books covering a wide spectrum ranging from Apple devices and cameras to photo editing software and ...

A licensed attorney with nearly a decade of experience in content production, Valerie Catalano knows how to help readers digest complicated information about the law in an approachable way. Her ...

Angelica Leicht is a personal finance editor focused on distilling complex financial topics into smart, relatable insights. With nearly two decades of experience in digital journalism, Angelica has ...

The best heart rate monitors are accurate, comfortable, and offer features that enhance the experience beyond beats per minute. The good news is that you can also receive all these benefits through a ...

Explore the 10 best generative AI courses to take in 2026, with options for hands-on training, certifications, and practical ...

What's the best AI data center infrastructure stock right now for investors? Seeking Alpha analysts Ricardo Fernandez and Petri Dish Reports weigh in. Ricardo Fernandez: In my view, the AI data center ...

Alana Benson is an investing writer who joined NerdWallet in 2019. She covers a wide variety of investing topics including stocks, socially responsible investing, cryptocurrency, mutual funds, HSAs ...

Just because you have antivirus software installed on your PC doesn't mean a zero-day Trojan can't steal your personal data. The top encryption software keeps you safe from malware (and the NSA). When ...

What is the best SSD for gaming? Most modern SSDs are fast enough to make for a usable gaming PC, and an upgrade might not boost your in-game frame rate. However, a top gaming SSD will ensure your PC ...

When the IBM PC was new, I served as the president of the San Francisco PC User Group for three years. That’s how I met PCMag’s editorial team, who brought me on board in 1986. In the years since that ...

We consider Structure Therapeutics as one of the most compelling risk-reward setups in the biotechnology sector and an attractive M&A candidate. The company's oral small molecule GLP-1 receptor ...